• info@reportsandmarkets.com
  • +44-020-3286-9338 (UK) +1-214-377-1121 (US)
  • Sign In
  • Register

Pharma & HealthcareGlobal Rosuvastatin Market Insights, Forecast to 2025

  • RnM2419430
  • |
  • 14 September, 2018
  • |
  • Global
  • |
  • 126 pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

This report studies the global market size of Rosuvastatin in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Rosuvastatin in these regions.
This research report categorizes the global Rosuvastatin market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

In 2017, the global Rosuvastatin market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Rosuvastatin market based on company, product type, application and key regions.

The various contributors involved in the value chain of Rosuvastatin include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Rosuvastatin include
AstraZeneca
Teva Pharmaceutical Industries
MSN Laboratories
Cadila Pharmaceuticals
LGM Pharma
Bal Pharma
Changzhou Pharmaceutical Factory
Jingxin Pharm
Zhejiang Hisun Pharmaceutical
HEC Pharm
Lunan Pharmaceutical
Nanjing Frochem Tech
Lianyungang Runzhong Pharmaceutical
Shandong Bechem Chemicals
CTX Life Sciences

Market Size Split by Type
Purity 98.0%
Purity 99.0%
Other
Market Size Split by Application
Tablet
Capsule
Others

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Rosuvastatin market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Rosuvastatin market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Rosuvastatin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Rosuvastatin with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Rosuvastatin submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Rosuvastatin are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Rosuvastatin market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

1 Study Coverage
1.1 Rosuvastatin Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Rosuvastatin Market Size Growth Rate by Type
1.4.2 Purity 98.0%
1.4.3 Purity 99.0%
1.4.4 Other
1.5 Market by Application
1.5.1 Global Rosuvastatin Market Size Growth Rate by Application
1.5.2 Tablet
1.5.3 Capsule
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Rosuvastatin Market Size
2.1.1 Global Rosuvastatin Revenue 2016-2025
2.1.2 Global Rosuvastatin Sales 2016-2025
2.2 Rosuvastatin Growth Rate by Regions
2.2.1 Global Rosuvastatin Sales by Regions
2.2.2 Global Rosuvastatin Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Rosuvastatin Sales by Manufacturers
3.1.1 Rosuvastatin Sales by Manufacturers
3.1.2 Rosuvastatin Sales Market Share by Manufacturers
3.1.3 Global Rosuvastatin Market Concentration Ratio (CR5 and HHI)
3.2 Rosuvastatin Revenue by Manufacturers
3.2.1 Rosuvastatin Revenue by Manufacturers (2016-2018)
3.2.2 Rosuvastatin Revenue Share by Manufacturers (2016-2018)
3.3 Rosuvastatin Price by Manufacturers
3.4 Rosuvastatin Manufacturing Base Distribution, Product Types
3.4.1 Rosuvastatin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Rosuvastatin Product Category
3.4.3 Date of International Manufacturers Enter into Rosuvastatin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Rosuvastatin Sales by Type
4.2 Global Rosuvastatin Revenue by Type
4.3 Rosuvastatin Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Rosuvastatin Breakdown Data by Application

6 North America
6.1 North America Rosuvastatin by Countries
6.1.1 North America Rosuvastatin Sales by Countries
6.1.2 North America Rosuvastatin Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Rosuvastatin by Type
6.3 North America Rosuvastatin by Application
6.4 North America Rosuvastatin by Company

7 Europe
7.1 Europe Rosuvastatin by Countries
7.1.1 Europe Rosuvastatin Sales by Countries
7.1.2 Europe Rosuvastatin Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Rosuvastatin by Type
7.3 Europe Rosuvastatin by Application
7.4 Europe Rosuvastatin by Company

8 Asia Pacific
8.1 Asia Pacific Rosuvastatin by Countries
8.1.1 Asia Pacific Rosuvastatin Sales by Countries
8.1.2 Asia Pacific Rosuvastatin Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Rosuvastatin by Type
8.3 Asia Pacific Rosuvastatin by Application
8.4 Asia Pacific Rosuvastatin by Company

9 Central & South America
9.1 Central & South America Rosuvastatin by Countries
9.1.1 Central & South America Rosuvastatin Sales by Countries
9.1.2 Central & South America Rosuvastatin Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Rosuvastatin by Type
9.3 Central & South America Rosuvastatin by Application
9.4 Central & South America Rosuvastatin by Company

10 Middle East and Africa
10.1 Middle East and Africa Rosuvastatin by Countries
10.1.1 Middle East and Africa Rosuvastatin Sales by Countries
10.1.2 Middle East and Africa Rosuvastatin Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Rosuvastatin by Type
10.3 Middle East and Africa Rosuvastatin by Application
10.4 Middle East and Africa Rosuvastatin by Company

11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Rosuvastatin
11.1.4 Rosuvastatin Product Description
11.1.5 Recent Development
11.2 Teva Pharmaceutical Industries
11.2.1 Teva Pharmaceutical Industries Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Rosuvastatin
11.2.4 Rosuvastatin Product Description
11.2.5 Recent Development
11.3 MSN Laboratories
11.3.1 MSN Laboratories Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Rosuvastatin
11.3.4 Rosuvastatin Product Description
11.3.5 Recent Development
11.4 Cadila Pharmaceuticals
11.4.1 Cadila Pharmaceuticals Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Rosuvastatin
11.4.4 Rosuvastatin Product Description
11.4.5 Recent Development
11.5 LGM Pharma
11.5.1 LGM Pharma Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Rosuvastatin
11.5.4 Rosuvastatin Product Description
11.5.5 Recent Development
11.6 Bal Pharma
11.6.1 Bal Pharma Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Rosuvastatin
11.6.4 Rosuvastatin Product Description
11.6.5 Recent Development
11.7 Changzhou Pharmaceutical Factory
11.7.1 Changzhou Pharmaceutical Factory Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Rosuvastatin
11.7.4 Rosuvastatin Product Description
11.7.5 Recent Development
11.8 Jingxin Pharm
11.8.1 Jingxin Pharm Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Rosuvastatin
11.8.4 Rosuvastatin Product Description
11.8.5 Recent Development
11.9 Zhejiang Hisun Pharmaceutical
11.9.1 Zhejiang Hisun Pharmaceutical Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Rosuvastatin
11.9.4 Rosuvastatin Product Description
11.9.5 Recent Development
11.10 HEC Pharm
11.10.1 HEC Pharm Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Rosuvastatin
11.10.4 Rosuvastatin Product Description
11.10.5 Recent Development
11.11 Lunan Pharmaceutical
11.12 Nanjing Frochem Tech
11.13 Lianyungang Runzhong Pharmaceutical
11.14 Shandong Bechem Chemicals
11.15 CTX Life Sciences

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Rosuvastatin Raw Material
13.1.2 Rosuvastatin Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer


captcha
Enter the code in the box:


captcha
Enter the code in the box:

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may not print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

 

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

 

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.


captcha
Enter the code in the box:



Summary:
Get latest Market Research Reports on Rosuvastatin . Industry analysis & Market Report on Rosuvastatin is a syndicated market report, published as Global Rosuvastatin Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Rosuvastatin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,900.00
$7,800.00
2,618.85
5,237.70
3,588.78
7,177.56
472,446.00
944,892.00
258,622.26
517,244.52
Add To Cart Credit card Logo

Related Reports


Reason to Buy